Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Session: New Antimicrobials in the Pipeline

47 - Nacubactam (OP0595): a Novel Triple-Action Diazabicyclooctane in Combination with Cefepime or Aztreonam

Monday, October 20, 2025
8:00 AM - 8:12 AM US ET
Location: B302-B304
Disclosure(s):
Hayato Okade, Ph.D: Meiji Seika Pharma Co., Ltd: Emploee